Log on / register
Feedback | Support | My details
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.
Collins CE, Gavin AL, Migone TS, Hilbert DM, Nemazee D, Stohl W
Arthritis Res Ther 2006, 8:R6
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.

Review   
Biomarkers as tools for improved diagnostic and therapeutic monitoring in systemic lupus erythematosis
Smith MF, Hiepe F, Dörner T, Burmester G
Arthritis Research & Therapy 2009, 11:255 (19 November 2009)
 [Abstract] [Full text] [PDF]
2.




Research article    
Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort
Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X
Arthritis Research & Therapy 2009, 11:R114 (23 July 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [F1000 Medicine]
3.


Review    
Developments in lupus 2006
Hansen A, Hiepe F, Dörner T
Arthritis Research & Therapy 2007, 9:215 (11 July 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.